- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/40 - Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
Patent holdings for IPC class C07D 209/40
Total number of patents in this class: 261
10-year publication summary
|
20
|
21
|
18
|
15
|
16
|
20
|
19
|
19
|
12
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 160 |
23 |
| Novartis Pharma AG | 180 |
15 |
| IFM Due, Inc. | 36 |
14 |
| City of Hope | 1017 |
7 |
| Cornell University | 3387 |
7 |
| Novita Pharmaceuticals, Inc. | 24 |
7 |
| Vertex Pharmaceuticals Incorporated | 1601 |
5 |
| Purdue Research Foundation | 3853 |
5 |
| China Pharmaceutical University | 347 |
4 |
| National and Kapodistrian University of Athens | 48 |
4 |
| VALO Health, Inc. | 186 |
4 |
| BioCryst Pharmaceuticals, Inc. | 179 |
3 |
| Council of Scientific & Industrial Research | 1431 |
3 |
| Georgetown University | 621 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 858 |
3 |
| Taipei Medical University | 224 |
3 |
| Glaxosmithkline LLC | 531 |
2 |
| F. Hoffmann-La Roche AG | 7839 |
2 |
| Boehringer Ingelheim International GmbH | 4510 |
2 |
| Massachusetts Institute of Technology | 10201 |
2 |
| Other owners | 143 |